Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors.
about
Immunotherapy for lung cancer: advances and prospectsCancer Stem Cells and Macrophages: Implications in Tumor Biology and Therapeutic StrategiesTumour progression and metastasisRegulation of epithelial-mesenchymal transition by tumor-associated macrophages in cancerPushing tumor cells towards a malignant phenotype: stimuli from the microenvironment, intercellular communications and alternative roadsTargeting tumor-associated macrophages to combat pancreatic cancerMicroenvironmental regulation of tumor progression and metastasisCancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.Tumor-associated macrophages promote Ezrin phosphorylation-mediated epithelial-mesenchymal transition in lung adenocarcinoma through FUT4/LeY up-regulationMicroRNA-26b inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting USP9X.EMT and inflammation: inseparable actors of cancer progression.Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophagesThe epigenetics of epithelial-mesenchymal plasticity in cancer.Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis.Tumor infiltrating lymphocytes (TIL) and prognosis in oral cavity squamous carcinoma: a preliminary study.Melanoma-initiating cells exploit M2 macrophage TGFβ and arginase pathway for survival and proliferation.miRNA expression in anaplastic thyroid carcinomas.Prognostic value of tumor-associated macrophages according to histologic locations and hormone receptor status in breast cancerAccumulation of FOXP3+T-cells in the tumor microenvironment is associated with an epithelial-mesenchymal-transition-type tumor budding phenotype and is an independent prognostic factor in surgically resected pancreatic ductal adenocarcinomaCD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition.Macrophage-tumor cell fusions from peripheral blood of melanoma patientsNG2 proteoglycan-dependent recruitment of tumor macrophages promotes pericyte-endothelial cell interactions required for brain tumor vascularization.Immune microenvironment in tumor progression: characteristics and challenges for therapyMacrophage depletion reduces postsurgical tumor recurrence and metastatic growth in a spontaneous murine model of melanoma.Contact-dependent carcinoma aggregate dispersion by M2a macrophages via ICAM-1 and β2 integrin interactions.Tumor-associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinomaNG2 Proteoglycan-Dependent Contributions of Pericytes and Macrophages to Brain Tumor Vascularization and Progression.Microenvironmental regulation of epithelial-mesenchymal transitions in cancerMurine mesothelioma induces locally-proliferating IL-10(+)TNF-α(+)CD206(-)CX3CR1(+) M3 macrophages that can be selectively depleted by chemotherapy or immunotherapy.Significance of interstitial tumor-associated macrophages in the progression of lung adenocarcinoma.Identifying causal networks linking cancer processes and anti-tumor immunity using Bayesian network inference and metagene constructs.Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo.Chronic Inflammation: Synergistic Interactions of Recruiting Macrophages (TAMs) and Eosinophils (Eos) with Host Mast Cells (MCs) and Tumorigenesis in CALTs. M-CSF, Suitable Biomarker for Cancer Diagnosis!Ovarian low and high grade serous carcinomas: hidden divergent features in the tumor microenvironment.Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer.Epithelial mesenchymal transition in drug resistance and metastasis of lung cancer.Nichotherapy for stem cells: there goes the neighborhood.Positive and negative influence of the matrix architecture on antitumor immune surveillance.Strategies to increase drug penetration in solid tumors.Tumor necrosis factor-alpha-converting enzyme activities and tumor-associated macrophages in breast cancer.
P2860
Q26750617-FD1E602C-B397-4ABF-826C-265F04D31AEEQ26765342-D0BE6681-15C1-4C9E-ADD1-817FFD1DA20AQ26766468-C4567343-B2C4-4E04-9A24-088F2C7322E9Q26773786-E550C907-5B5A-4F75-BE5C-15E5E5E024ADQ26830075-D697E413-FEC0-4ABB-9B89-BAF760A78ED4Q28076103-637C4E73-39F0-4FFF-814C-F6B04AE45D23Q29615504-FF9844D5-3988-4CD7-9FAF-01C90DAA23A4Q30358706-21C2352B-C143-43A1-BEB3-02A80726D41FQ33709659-120A9A87-AE64-44AE-A8A8-8C2A158A3FA7Q33775464-03E843C8-DCAB-48C4-935C-3E58E4CF7081Q33869755-F12E85A8-E410-454A-8ED3-179BA60D5B73Q34044797-B9C25A51-17E4-4C70-AF61-F4E1BBD6C3F6Q34310378-395E91A8-EB83-45D6-A030-30AE0E541D1EQ34399827-774F5DD6-DDDC-4DBF-8187-A83180E46AC3Q34718331-C0DED175-23ED-4521-97A5-093FC264EC02Q35067933-3D4F3A02-D4E8-4D98-9080-FD4EEA079D28Q35230925-1ECD8AA5-DAD9-47CC-957F-88047D6F2752Q35463975-DBEF7116-D10E-448D-80EF-9B39877DF630Q35551974-D88FDF27-6415-4881-8117-85D73C9E3D19Q35742418-23C4C172-C3B8-4059-858B-05EA9C045D99Q35744035-BDE20A34-039B-496A-A630-C091A59B1182Q35799099-E7562A0C-F38D-4AAC-8471-B581155174DAQ36178400-ABA69920-7C20-46D7-8A0A-860B6D4B3663Q36356092-EF10AC0C-D6A2-497C-956A-F498B0FC8C90Q36413170-53713F2F-AA78-40E6-9682-2D752888397DQ36466730-AC3A8CF2-DF8D-445F-8229-5A9A8EDFD1BFQ36552576-F732B8FA-3EAC-483D-B2C8-56E0EB2655D1Q36831337-BBB5098D-A4C0-4552-B6D1-7BCC258954B9Q37078960-656EE077-B91B-44F4-A7FC-47F35A47ED30Q37581818-D35613C4-68ED-486E-94A1-D661B8A8FB63Q37621735-EF9798E0-AC55-4F6F-AC78-840A8E8CE527Q37631248-A9B7FB9B-DF2A-4AA1-96FE-01B77BB3B5F3Q37693490-0EE16D07-E9E9-40A8-ABD9-7AC8826B404BQ37708746-A3B871A9-1C67-4BBC-A721-02A38FB104C1Q37714611-4F385478-B69F-4609-BC89-B9A926C9A476Q38054713-456A6619-E6A1-48E1-AC34-53B408043C74Q38058023-1D56B008-11C0-441A-9EBD-C8D6B55539C6Q38104594-FC14E829-8A9F-41CF-8FF6-2CC1F2D445AEQ38125197-411D9A31-219E-4889-AB92-89F1286240F8Q38144933-9220D452-B924-4638-A3E5-DF54500A02ED
P2860
Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors.
@ast
Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors.
@en
Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors.
@nl
type
label
Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors.
@ast
Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors.
@en
Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors.
@nl
prefLabel
Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors.
@ast
Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors.
@en
Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors.
@nl
P2093
P2860
P356
P1433
P1476
Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors.
@en
P2093
Alex Soltermann
Anne-Katrine Bonde
Reto A Schwendener
Sushil Kumar
Verena Tischler
P2860
P2888
P356
10.1186/1471-2407-12-35
P407
P577
2012-01-24T00:00:00Z
P5875
P6179
1019135354